onesano S.A. (WSE:ONO)

Market Cap	47.43M -23.9%
Revenue (ttm)	11.93M +11.6%
Net Income	-4.79M
EPS	-0.07
Shares Out	65.88M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,368
Average Volume	49,109
Open	0.7200
Previous Close	0.7200
Day's Range	0.6740 - 0.7300
52-Week Range	0.5700 - 1.1400
Beta	0.12
RSI	64.15
Earnings Date	Apr 16, 2026

About onesano

onesano S.A. engages in the research and development in the areas of dietetics, animal nutrition, bioremediation, and agrotechnological processes in Poland. The company provides human dietary supplement products under the Estrovita brand. It also offers Yarrowia Equinox; Yarrowia Canifelox; and dietary supplements, functional foods, and cosmetic raw materials. It sells its products through chain pharmacies, pharmaceutical wholesalers, drugstores, e-commerce, veterinary offices, zoological and veterinary wholesalers, animal feed and supplementar...

• Industry: Chemicals
• Sector: Materials
• Founded: 1995
• Employees: 44
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: ONO

Financial Performance

In 2025, onesano's revenue was 11.93 million, an increase of 11.58% compared to the previous year's 10.69 million. Losses were -4.79 million, -17.32% less than in 2024.